Othman Ihab S, Gharieb Hesham M, Ibrahim Hani M G
Department of Ophthalmology, Faculty of Medicine, Cairo University, Giza, Egypt.
Eye World Hospital, Giza, Egypt.
Saudi J Ophthalmol. 2022 Jul 11;36(1):102-106. doi: 10.4103/sjopt.sjopt_36_20. eCollection 2022 Jan-Mar.
To evaluate the outcome and complications after implantation of the Boston type I keratoprosthesis (Kpro) in two groups of eyes.
We retrospectively reviewed records of 28 eyes with failed Penetrating keratoplasty (PKP) (Group A) and 31 eyes with severe ocular surface diseases who implanted Kpro. Follow-up was performed for a mean 37 months. Primary outcomes were Kpro retention and visual improvement, secondary outcomes included the occurrence of complications as endophthalmitis, retro-prosthesis membrane (RPM), intraocular pressure (IOP) abnormalities, posterior capsule opacification (PCO), graft thinning and extrusion.
Visual improvement was achieved in 20 eyes in Group A, and in 19 eyes in Group B. In group A, the prosthesis was retained in 25 eyes, while prosthesis retention in Group B was in 26 eyes. Group A had higher rates of PCO, high IOP, soft IOP, and graft thinning. Group B had higher risk of RPM, and endophthalmitis. Two eyes in Group A, and Five eyes in Group B required redo procedure.
The Boston Kpro type I is an effective procedure in eyes with high risk of keratoplasty failure and in severe ocular surface diseases, it has a high retention rate, higher in cases following failed PKP.
评估两组眼睛植入波士顿I型角膜移植假体(Kpro)后的结果及并发症。
我们回顾性分析了28例穿透性角膜移植术(PKP)失败的眼睛(A组)和31例植入Kpro的严重眼表疾病患者的眼部记录。平均随访37个月。主要结局指标为Kpro的保留情况和视力改善情况,次要结局指标包括眼内炎、假体后膜(RPM)、眼压(IOP)异常、后囊膜混浊(PCO)、植片变薄和脱出等并发症的发生情况。
A组20只眼视力得到改善,B组19只眼视力得到改善。A组25只眼保留了假体,B组26只眼保留了假体。A组PCO、高眼压、低眼压和植片变薄的发生率较高。B组发生RPM和眼内炎的风险较高。A组2只眼和B组5只眼需要再次手术。
波士顿I型Kpro对角膜移植失败风险高的眼睛和严重眼表疾病是一种有效的手术方法,其保留率高,PKP失败后的病例保留率更高。